Kantonsspital St. Gallen (HOCH Health Ostschweiz); academic affiliation Universität Basel

Number of service categories this organization offers.

• ✓1 service category listed

PubMed publications + ClinicalTrials.gov active trials linked to this organization.

• —0 PubMed publications
• —0 active clinical trials

How easy it is for patients and families to reach this organization.

• ✓Has website
• ✓Has phone number
• ✓Has email
• ✓Has street address
• ✓Has map coordinates

Breadth of direct support offered to patients and families.

• —In-person support groups
• —Online support groups
• —Caregiver resources in services
• —Funds or provides home care
• —Children's resources

Percentage of profile fields with information.

• ✓Name
• ✓Type
• ✓Country
• ✓State / region
• ✓Address
• ✓Phone
• ✓Email
• ✓Website
• ✓Mission

Connections to research consortia and ALS networks.

• —Part of a consortia
• —International reach
• —Publishes research
• —Maintains an ALS database
• ✓Mentions a known network (NEALS, ENCALS, TRICALS, etc.)

No community reviews yet — this dimension is excluded from the overall score.

• —No reviews yet

Contact

Mission

Swiss flagship ALS research + clinical center — major European ALS trial site; MUNIX biomarker development. Lead: **Prof. Dr. Markus Weber**, MD — Professor of Neurology, **University of Basel**; Diploma in Clinical Neurology from University of London Queen Square; MD University of Bonn; neuromuscular fellowship at **University of British Columbia in Vancouver** (1997-2000); **ENCALS executive committee member**; **ENMC research committee member**; former co-chair of the **European Academy of Neurology scientific panel on ALS and FTD**; **PRECISION-ALS named expert**. Patient volume: ~250 ALS patients from all over Switzerland in current follow-up (TRICALS figure); 200 patients per earlier ENCALS listing; the major Swiss ALS referral center Visit frequency: Every 3 months (standard multidisciplinary review protocol) Signature research contribution: Development of the MUNIX (Motor Unit Number Index) — a widely adopted non-invasive biomarker for tracking motor unit loss in ALS, used as an outcome measure in international ALS clinical trials Research areas: Outcome measures; clinical neurophysiology; trial design; cannabinoid research; quality-of-life research; genetic research (including collaborative DNA banking)